The BBC reports on new research describing the structure of telomerase, an enzyme long known to be implicated in tumor cells. The study, from scientists at the Wistar Institute in Philadelphia, "could lead to drugs which switch it off," the article says. The structural information could be key to providing molecular targets for therapeutics.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.